Literature DB >> 9041487

Co-morbidity in patients with abdominal aortic aneurysm.

R Kanagasabay1, H Gajraj, L Pointon, R A Scott.   

Abstract

OBJECTIVES: Selection for surgery of patients with abdominal aortic aneurysm (AAA) depends on an assessment of risk from operation compared with risk from aneurysm rupture. A study was performed to assess the levels of co-morbidity and to see whether co-morbidity was different in people with a normal aorta after ultrasonographic examination than in those with an aneurysmal aorta. SETTING AND METHODS: Over a two year period 5392 people (2341 men, 3051 women) aged 65-80 were screened using B-mode linear ultrasound, with maximum measurements taken of transverse, anteroposterior diameters, or both. All subjects were given a questionnaire seeking a history of angina, stroke, claudication, myocardial infarct, respiratory problems, and diabetes.
RESULTS: 218 men and women were found to have an AAA of 3 cm or greater. The results of the questionnaire were analysed using logistic regression whereby all the co-morbid conditions were adjusted for each other and for smoking, sex, and age. The only conditions which were significantly associated with AAA in both sexes were myocardial infarction with an odds ratio (OR) of 1.66 (95% confidence interval (CI) 1.06 to 2.60) and claudication with an OR of 1.68 (95% CI 1.17 to 2.42). The association between angina and AAA was of borderline significance (OR = 1.52, 95% CI 1.00 to 2.30). Stroke was significantly associated only in women, with an OR of 3.71 (95% CI 1.42 to 9.69). Rates of diabetes and respiratory disease were not significantly different between people with AAA and normal aortas.
CONCLUSIONS: These findings show there is significantly higher co-morbidity in people with ultrasound detected AAA, which might influence outcome from surgery and long term survival.

Entities:  

Mesh:

Year:  1996        PMID: 9041487     DOI: 10.1177/096914139600300410

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  4 in total

1.  Targeted Gold Nanoparticles as an Indicator of Mechanical Damage in an Elastase Model of Aortic Aneurysm.

Authors:  Brooks A Lane; Xiaoying Wang; Susan M Lessner; Naren R Vyavahare; John F Eberth
Journal:  Ann Biomed Eng       Date:  2020-04-02       Impact factor: 3.934

2.  Insurance status predicts access to care and outcomes of vascular disease.

Authors:  Jeannine K Giacovelli; Natalia Egorova; Roman Nowygrod; Annetine Gelijns; K Craig Kent; Nicholas J Morrissey
Journal:  J Vasc Surg       Date:  2008-06-30       Impact factor: 4.268

Review 3.  Matrix Metalloproteinase in Abdominal Aortic Aneurysm and Aortic Dissection.

Authors:  Eithne M Maguire; Stuart W A Pearce; Rui Xiao; Aung Y Oo; Qingzhong Xiao
Journal:  Pharmaceuticals (Basel)       Date:  2019-08-06

4.  Abdominal aortic aneurysm events in the women's health initiative: cohort study.

Authors:  Frank A Lederle; Joseph C Larson; Karen L Margolis; Matthew A Allison; Matthew S Freiberg; Barbara B Cochrane; William F Graettinger; J David Curb
Journal:  BMJ       Date:  2008-10-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.